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Background: To evaluate the evolution of patients rehabilitated with endosseous implants after oral cancer treat-
ment. 
Material and Methods: An observational retrospective study was carried out between 1991 and 2011 with a sample 
consisting of patients with oral cancer who had been referred for rehabilitation to the Prosthetics Rehabilitation 
Unit from the Oral and Maxillofacial Surgery Unit of the Virgen del Rocío University Hospital. All these patients 
have overcome oral cancer, and have a five-year follow-up after their oral rehabilitation. Age, sex, smoking habits, 
oral pathology, type of treatment of oral pathology, edentulism, receptor bone, prosthetic rehabilitation, timeouts, 
working time and evolution were studied. SPSS Statistics was used for statistical analysis of the variables studied. 
A chi-square test centered on the survival rate of implants placed in relation to the other recorded variables was 
performed. 
Results: 17 patients were treated for cancer and rehabilitated with implant prosthetics, with a total of 106 implants 
placed. 32% were partially edentulous patients (4 patients), and 68.2% were completely edentulous patients (13 
patients). An implant survival rate of 87.7% was observed at 5 years. In the upper maxilla, the survival rate was 
79.2%, and in the mandible 93.7% (p = 0.03). 91 implants were placed in native receptor bones (85.8%), with only 
15 implants placed in grafted receptor bone (14.2%). According to the type of receptor bone, in native receptor 
bones, 9 implants failed (90.1% of implant survival), while in grafted receptor bones, 4 implants failed (overall 
73.3% implant survival rate) (p = 0.08). 
Conclusions: Although a high survival rate was obtained in this study (with lower survival rates seen in mandible 
and grafted bone), prospective long-term studies are needed to assess the relationship between radiotherapy doses 
and the time required for implant placement, prosthetic protocol used, and type of implants used in patients selected 
for prosthetic rehabilitation.
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Introduction
Implantology has led to significant changes in the plan-
ning of prosthetic rehabilitation, mainly in patients 
who have suffered anatomical alterations after surgical 
treatment of cancer (1-3). Implants in fully edentulous 
patients help to maintain bone volume, stomatognathic 
function, masticatory muscle activity and aesthetics, all 
while positively impacting patient psychological health 
and quality of life (4,5). In the case of partial edentulism, 
the use of endosseous implants in the support of pros-
theses against the teeth usually improves stability and 
retention of the prosthesis (6).
Although prosthetic rehabilitation has clear benefits for 
patient quality of life, it is not a systematic treatment 
commonly used in oncology patients. Patient medical 
history and the prognosis should be thoroughly eva-
luated. Likewise, the patient must show a willingness 
to receive implant rehabilitative treatment, as they must 
commit to maintaining it (7,8).
The presence of cancer recurrence more than two years 
after the treatment of the underlying pathology is less 
than 5% (9), so it seems reasonable for more advanced 
treatments to be performed only when the patient has 
surpassed this high-risk period. The patient’s overall si-
tuation should be evaluated, and waiting time should be 
established according to their risk for osseointegration 
of the implants (10).
Fixed-implant prostheses are more aesthetic and are ai-
med at increasing patient satisfaction, although they do 
not always achieve this. The requirements for this type 
of prosthesis are very high, and due to previous surgeries 
performed on patients with cancer, in addition to being 
more difficult to place and attain adequate emergency 
implants, they involve greater complexity of occlusal 
stability and more difficult maintenance and revision of 
the less accessible area (11).
The placement of implant-assisted rehabilitation pros-
theses in patients with cancer has shown a high degree 
of satisfaction and there are numerous advantages: they 
require a smaller number of implants, facilitate oral hy-
giene, make it easier to obtain greater occlusal stability 
and good distribution of occlusal forces, and are a less 
expensive treatment. In turn, these prostheses help resto-
re deficiencies in white and hard tissue without need for 
additional surgeries (12).
The objective of this study was to evaluate the evolution 
of patients rehabilitated with endosseous implants after 
treatment of oral pathology (primarily oral cancer) refe-
rred to the Unit of Prosthetic Rehabilitation of the Uni-
versity Hospital Virgen del Rocío between 1991-2011.
Material and Methods 
An observational retrospective descriptive study of pa-
tients rehabilitated with endosseous implants after oral 
cancer treatment during the years 1991–2011 was ca-
rried out, analyzing the type, characteristics, treatment 
and follow-up of the oral rehabilitation methodology 
implemented. The follow-up period was 5 years.
The inclusion criteria were patients with malignant neo-
plasia who after their treatment had been referred to the 
Unit of Prosthetic Rehabilitation of the Oral and Maxi-
llofacial Surgery Unit of the University Hospital Virgen 
del Rocío for rehabilitation with a five-year follow-up 
period. Exclusion criteria were patients previously re-
habilitated by implant prostheses, patients for whom re-
habilitation treatment was contraindicated, and patients 
from whom information regarding the variables studied 
could not be obtained.
Information from patients included in the study obtained 
from the Hospital Clinical Histories of the Prosthetic 
Rehabilitation Unit was entered into a data collection 
sheet. The variables studied prior to treatment, during 
prosthetic treatment and after treatment were all recor-
ded. These variables were age, sex, smoking habits, oral 
pathology, type of treatment of the oral pathology, eden-
tulism, implant receptor bone, prosthetic rehabilitation, 
timeouts, working time and implant survival rate after 
5 years.
Smoking habits were classed into 1 of 4 categories: 0–10 
cigarettes per day, 10–20 cigarettes per day, 20-30 ciga-
rettes per day and more than 30 cigarettes per day.
The Alcohol Use Disorders Identification Test (AUDIT) 
was used to assess patients’ alcohol consumption (13). 
Risk categories in the typical consumption table were: 
low-risk drinkers, ≤ 17 SDU (170 g) for females and 
≤ 28 SDU (280 g) for males per week; moderate-risk 
drinkers, > 17 SDU for females and > 28 SDU for males 
per week; and high-risk drinkers, > 28 SDU for females 
and > 42 SDU for males per week (14).
We have defined (and recorded) implant survival as 
when an implant is successfully kept in the mouth and 
performing its function. The present study was approved 
by the Ethics Committee of the University of Seville, 
and patients provided consent for their clinical data to 
be used for scientific purposes without being identified. 
SPSS Statistics was used to analyze the variables stu-
died. A chi-square test (for the study of the distribution 
of the different variables in the sample) was also carried 
out. 
Results
A total of 17 patients were treated with oncological pa-
thology and rehabilitated with implant prostheses, with 
a total of 106 implants placed. The pre-prosthetic varia-
bles studied in patients are shown by age in Table 1, whi-
le the post-surgical variables are found in Table 2 and 3.
Sample characteristics 
Regarding age, 3 patients (11.8%) fell under the 30–39 
to 40–49 year age group, 5 patients between 50–60 years 
old (29.4%), and 8 patients older than 60 (47%). 29.4% 
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Table 1: Patient pre-prosthetic variables by age.
(5 patients) of the sample were women, and 70.6% were 
men (12 patients). 14 patients (82.4%) were smokers and 
3 (17.6%) were non-smokers. The total number of pa-
tients who consumed alcohol was 9 (53%), with prudent 
drinkers (3 patients), moderate drinkers (3 patients) and 
excessive drinkers (3 patients) each making up 33.3% 
of this population. None of the evaluated patients con-
tinued smoking or drinking after pathology diagnosis.
Of the total sample, 15 patients presented with epider-
moid carcinoma (88.2%), one patient with osteosarcoma 
(5.9%), and one patient with cavum lymphoepithelioma 
(5.9%). The most frequent localization for squamous cell 
carcinoma was in the floor of the mouth (40%), retro-
molar trigone (20%) and tongue (13.3%) (Table 1). The 
most frequent modality used to treat patients was sur-
gery with postoperative radiotherapy (47%), followed 
by surgery as the only treatment for that particular case 
alone (23.5%) and only in that case, with 17.6% of the 
cases being performed after surgery with a combination 
of radiotherapy and chemotherapy (Table 1).
Implant and treatment characteristics
A total of 106 implants were placed. Data on the type of 
bone and the type of cancer treatment performed can be 
found in Table 2. Of the 17 patients rehabilitated, 29% 
were partially edentulous patients (5 patients) and 71% 
were fully edentulous (12 patients), type of edentulism, 
timeouts and working time by age could be seen in  Ta-
ble 3. In 17 patients, 19 prosthetic rehabilitations were 
performed on implants: 10 overdentures (52.6%); 7 hy-
brid-type fixed prostheses (36.8%) and 2 metal-ceramic 
fixed prostheses (10.6%).
Of the 106 total implants placed, a total of 43 implants 
(40.5%) were placed in the upper maxillary bone, with 
63 implants (59.4%) placed in the lower jaw. 91 im-












Type	of	treatment	 Surgical	 Radio	 Radio	&	
chem	
Chem	 		 Surgical	 Radio	 Chem	 		 		
Implants	placed	 		 Total	(%)	 		 Total	(%)	 TOTAL	(%)		
Maxilla	 6	 20	 6	 4	 36	(83.7)	 4	 3	 	 7	(16.3)	 43	(40.5)	
Mandible	 8	 26	 19	 2	 55	(87.3)	 	 4	 4	 8	(12.7)	 63	(59.4)	
Total	(%)	 14	(15.4)	 46	(50.5)	 25	(27.5)	 6	(6.6)	 91	(85.8)	 4	(26.7)	 7	(46.7)	 4	(26.7)	 15	(14.2)	 106	
Implants	failure	
			
Maxilla	 5	 2	 	 7	(77.8)	 2	 	  2	(22.2)	 9	(21)	
Mandible	 2	 	 2	(50)	 	 2	 2	(50)	 4	(6.3)	
Total	(%)	 7	(77.7)	 2	(22.2)	 9	(69.2)	 2	(50)	 2	(50)	 4	(30.8)	 13	(12.3)	
Cause	of	failure	
Opening	limitation	  	-	 2	 	  2	(13.3)	 2	(15.4)	
No	osseointegration	 	   	-	 	 2	 2	(13.3)	 2	(15.4)	
Pathology	recurrence	 6	 6	(6.5)	  	-	 6	(46.2)	
Incorrect	placement	 1	 1	(1)	 	-	 1	(7.6)	
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Table 2: Implant survival variables.
Table 3: Post-surgical variables of rehabilitated patients by age. 
plants (85.8%) were placed in native receptor bone, of 
which 36 were placed in the maxilla (83.7%) and 55 
in the mandible (87.3%) (Table 2). Only 15 implants 
(14.2%) were placed in grafted receptor bone, of which 
7 implants were placed in the upper jaw (16.3) and 8 
implants were placed in the lower jaw (12.7%) (Table 2).
Post-rehabilitation follow-up
All patients had a minimum follow-up period of 5 years, 
during which period only 2 patients in the sample studied 
presented recurrence of tumoral pathology (9%), being 
more frequent in patients over the age of 50 (100%). 
An implant survival rate of 87.7% was found after 5 
years of oncological treatment. Of the total number of 
implants placed, 13 implants failed (12.3%), of which 
9 implants were placed in the maxilla (79.2% implant 
survival rate) and 4 implants in the lower jaw (93.7% 
implant survival rate) (p = 0.03). Regarding the type of 
receptor bone, 9 failed implants had been placed in na-
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tive receptor bone (90.1% implant survival) and 4 failed 
implants in grafted receptor bone (73.3% implant survi-
val) (p = 0.08; Table 2).
Discussion
Prosthetic rehabilitative treatment with or without dental 
implants leads to an improvement in patient’s quality of 
life through functionality, aesthetics and social rehabili-
tation (5).
Chiapasco et al. (15) presented the exclusion criteria for 
treatment with implants: a) patients with a poor prog-
nosis or whose health is compromised systemically; B) 
patients who have undergone resection of the posterior 
part of the jaw or mandible with sufficient remaining 
dentition to ensure acceptable chewing; C) patients with 
recurring oral carcinoma who continue to consume alco-
hol or tobacco; and d) non-cooperative patients.
Long-term data collection of patients with oral tumors 
is difficult as their life expectancy is often reduced. One 
study found that 50% of patients with oral tumors died 
within 2.3 years of ending treatment, i.e. before reaching 
5 years of survival (16). In this case, all patients survived 
after 5 year of oncological treatment, although 2 of them 
had experienced a relapse during this period, and as a 
result 6 dental implants had to be removed.
Smoking and regular alcohol consumption are often as-
sociated with the development of oral tumors, increasing 
this risk from 6 to 15. After quitting, this risk decreases 
and may disappear within 5-10 years (17). In this sam-
ple, 59% of patients smoked, data very close to revealed 
shown by Katsoulis (18) in a study in 2013 with 54%. 
Squamous cell carcinoma was observed in 88% of this 
patients, a percentage higher than that observed by other 
authors with 78% (18).
Timeouts
The ideal time interval for radiotherapy treatment so as 
not to affect osseointegration of implants is a matter of 
some debate (19). Some authors advocate immediate 
placement after ablative surgery (during the same sur-
gical procedure) (20). The advantages of this procedure 
are that the implant will have a better osseointegration 
before radiotherapy, only one procedure is needed, and 
speech, mastication or aesthetics are either unaltered or 
can be treated with hyperbaric oxygen. The main disad-
vantages include added risk for the patient, as radiothe-
rapy treatment must be delayed, possible postoperative 
complications respective surgery, and even recurrence 
of the underlying pathology.
Authors such as Hancock (21) and Brogniez (7) suggest 
that a waiting period of 6 months may be sufficient. Ac-
cordingly, Vish et al. (22) conclude that six months after 
completion of radiotherapy, the success rate for implant 
survival is not affected. The difference in survival percen-
tages between implants inserted <1 year and ≥ 1 year after 
irradiation is not significant (76% and 81%, respectively). 
Other studies (23,24) prefer a minimum waiting period 
of 24 months, since this period allows for consolidation 
of the patient’s health status and can rule out related tu-
mor pathologies and facilitate recovery of the maxilla 
with adequate vascularization, consolidation of the re-
construction area, restoration of soft tissues affected by 
the treatment and, not least, the patient’s own psycho-
logical state. In this study all implants were deferred. 
Although some patients in this sample were rehabili-
tated within two years of completing cancer treatment, 
the vast majority of patients were rehabilitated after this 
period (> 70%). An implant survival rate of 87.7% was 
obtained after 5 years of follow-up, with 79.2% in the 
upper jaw and 93.7% in the mandible.
More than 2 years were required in some patients for 
various reasons: they had overcome the illness but they 
were not mentally prepared to undergo surgery, they did 
not want to have another surgery at that time, or they 
could not attend their appointment in the rehabilitation 
unit. The protocol used in this study considers the resti-
tution of basic functions by the patient to be essential, 
focusing initially on the restoration of health status af-
ter the surgical treatment of oncological pathology, and, 
once achieved, the subsequent placement of endosseous 
implants.
Implant survival 
Combination therapy (radiotherapy and chemotherapy) 
for tumors and follow-up implantation for functional re-
construction are considered necessary in patients with 
head and neck cancers (25). Although radiation thera-
py is commonly applied to the cancerous tumor as an 
important means of therapy, it can provoke changes in 
the patient’s soft and hard tissues. Implant failure can 
occur at different times, although it is most likely to oc-
cur within the first few months after placement, before 
the prosthetic phase begins (19,24). In this study, two 
implants failed due to necrosis of the receptor bone after 
the patient had been treated with chemotherapy and ra-
diotherapy, although a 12-month period after completion 
of oncologic treatment was expected (2.2%).
Yerit et al. (26) propose that implants be placed in areas 
with higher quality bone, as surgical trauma on bone of 
low quality, along with the effects of the radiotherapy 
treatment, can diminish the capacity of osseointegration 
or lead to osteoradionecrosis. All of these changes are 
considered detrimental to implant survival. Bone loss 
around implants can occur, often the result of contami-
nation by a mechanical or combined infectious agent, 
but it is rarely associated with the development of a ma-
lignant lesion.
In their 2002 study, Visch et al. (22) evaluated diffe-
rences in survival rates according to location of the im-
plants and the radiation intensity of radiotherapy. With 
respect to implants placed in locations where radiation 
was given at less than 50 Gy, 19 of 207 implants fai-
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led, achieving a survival rate of 84% at 10 years. In 
locations where radiation was greater than 50 Gy, the 
survival rate was 71%. Jisander et al. (27) observed 
that most complications occurred at doses greater than 
50 Gy. This may be due to the reduction in vasculari-
zation that occurs when bone is irradiated at that dose. 
Anatomical characteristics may also influence implant 
survival rates in the maxilla and mandible (79.2% vs. 
93.7%, p = 0.03).
Kanchan et al. (28) assessed the rate of osseointegration 
(ROI) and overall 5-year survival rate (OSR) of implants 
placed in native and grafted mandibles after ablative 
surgery, either with or without radiation therapy, in an 
Indian population. The ROI and OSR for implants was 
88% and 77%, respectively. Nasser in 2013 (29) studied 
the survival of implants in patients who had been irra-
diated after diagnosis of oral cancer and found that in 
34 articles, implants in post-radiation patients showed 
an average survival rate of 88.9% (over 3,775 implants). 
These results are similar to those found in this study, in 
which a survival rate of 87.7% was found at 5 years of 
follow-up. In this study, the high survival rate may be 
due to adequate choice of patients and to the rigorous 
protocol applied in the Oncology Rehabilitation Unit.
Conclusions
In patients treated for carcinoma in the oral cavity, the-
re is no consensus as to the timeouts needed to achieve 
successful survival after placement of endosseous im-
plants or for placement of prostheses. Although a high 
survival rate was obtained in this study (with a slightly 
lower survival rate observed in implants placed in graf-
ted bone and maxillary bone), the limited sample size 
makes further prospective long-term studies necessary 
in order to evaluate the relationship between radiothera-
py doses, waiting time required for the placement of the 
implants, prosthetic protocols followed, and the type of 
patient selected for prosthetic rehabilitation.
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